| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 11.893 | 47.801 | 66.938 | 72.569 | 138.477 |
| Total Income - EUR | - | - | - | - | - | 11.893 | 47.801 | 66.938 | 72.569 | 140.369 |
| Total Expenses - EUR | - | - | - | - | - | 1.692 | 3.808 | 6.080 | 13.167 | 26.565 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 10.201 | 43.993 | 60.858 | 59.402 | 113.805 |
| Net Profit/Loss - EUR | - | - | - | - | - | 9.860 | 42.587 | 59.164 | 58.785 | 109.858 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Omaxis Ra Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 489 | 98 | 0 | 18.047 |
| Current Assets | - | - | - | - | - | 11.072 | 42.575 | 60.751 | 89.552 | 105.239 |
| Inventories | - | - | - | - | - | 0 | 0 | 428 | 0 | 0 |
| Receivables | - | - | - | - | - | 3.119 | 10.562 | 777 | 8.042 | 84.738 |
| Cash | - | - | - | - | - | 7.954 | 32.013 | 59.547 | 81.511 | 20.502 |
| Shareholders Funds | - | - | - | - | - | 9.902 | 42.628 | 59.213 | 88.737 | 109.907 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.171 | 436 | 1.637 | 815 | 13.380 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Omaxis Ra Medical S.r.l.